About
Profile
Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine® approach to develop medicines that transform the lives of patients with rare neurological disorders. Ovid has a broad pipeline of potential first-in-class medici
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
OVID
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Ovid Therapeutics GAAP EPS of -$0.22 misses by $0.19, revenue of $0.14M
- Ovid Therapeutics reports Q3 results
- Ligand Pharmaceuticals acquires 13% of soticlestat royalties from Ovid Therapeutics for $30M
- Ovid Therapeutics GAAP EPS of -$0.18 beats by $0.03
- Ovid Therapeutics added to Russell 3000 Index
- Ovid Therapeutics GAAP EPS of -$0.19 misses by $0.02, revenue of $0.07M beats by $0.05M
- Ovid to invest $10M in Graviton to license neuro disease drug candidate
- Ovid Therapeutics GAAP EPS of -$0.16 beats by $0.02
- Ovid Therapeutics GAAP EPS of -$0.17 beats by $0.04
- Ovid Therapeutics GAAP EPS of -$0.21 beats by $0.04
- Ovid Therapeutics GAAP EPS of -$0.23 misses by $0.02, revenue of $1.45M
- Ovid Therapeutics GAAP EPS of -$0.38 misses by $0.22
- Xenon draws buyout speculation after Zogenix deal
- Ovid Therapeutics inks licensing deal with AstraZeneca in epilepsies and other neuropathic conditions
- Ovid Therapeutics EPS beats by $0.03
- Small biotechs warn Biden, lawmakers on drug price bill impact on R&D
- Ovid Therapeutics EPS misses by $0.06
- Ovid Therapeutics names Jason Tardio Chief Operating Officer
- Ovid Therapeutics appoints Jeff Rona as CFO
- Ovid Therapeutics EPS beats by $1.80, beats on revenue
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| November 11, 2021 | - / -0.1657 | - / - | |
| August 16, 2021 | -0.23 / -0.164 | - / - | |
| May 13, 2021 | 2.53 / 1.45 | 208.38M / 100.53M |
Beat! |
| April 1, 2021 | - / -0.3099 | - / 4.16M | |
| March 15, 2021 | -0.34 / -0.3056 | 5.7M / 4.16M |
Beat! |
| November 12, 2020 | -0.28 / -0.3504 | 6.91M / 100K | |
| August 10, 2020 | -0.41 / -0.36 | - / - | |
| May 7, 2020 | -0.37 / -0.33 | - / - | |
| March 11, 2020 | -0.35 / -0.41 | - / - |
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 | 3.210 | 3.140 |
3.270
|
3.140
|
189.26K | 1.58% | ||||
| Mar 17 | 3.160 | 3.090 |
3.180
|
3.090
|
130.42K | 2.27% | ||||
| Mar 16 | 3.090 | 3.110 |
3.130
|
3.070
|
171.89K | -1.28% | ||||
| Mar 15 | 3.130 | 3.130 |
3.190
|
3.105
|
84.51K | -2.19% | ||||
| Mar 14 | 3.200 | 3.310 |
3.360
|
3.150
|
122.34K | -5.33% | ||||
| Mar 11 | 3.380 | 3.500 |
3.550
|
3.370
|
126.47K | -3.15% | ||||
| Mar 10 | 3.490 | 3.380 |
3.490
|
3.380
|
123.05K | 1.16% | ||||
| Mar 9 | 3.450 | 3.390 |
3.495
|
3.390
|
522.46K | 2.37% | ||||
| Mar 8 | 3.370 | 3.330 |
3.460
|
3.300
|
427.56K | 0.90% | ||||
| Mar 7 | 3.340 | 3.350 |
3.390
|
3.300
|
145.22K | 0.30% | ||||
| Mar 4 | 3.330 | 3.260 |
3.340
|
3.260
|
107.50K | 1.22% | ||||
| Mar 3 | 3.290 | 3.460 |
3.460
|
3.282
|
127.04K | -4.64% | ||||
| Mar 2 | 3.450 | 3.420 |
3.540
|
3.370
|
176.77K | 1.17% | ||||
| Mar 1 | 3.410 | 3.380 |
3.440
|
3.330
|
120.98K | 0.59% | ||||
| Feb 28 | 3.390 | 3.220 |
3.400
|
3.160
|
196.20K | 3.67% | ||||
| Feb 25 | 3.270 | 3.190 |
3.280
|
3.180
|
99.78K | 2.51% | ||||
| Feb 24 | 3.190 | 2.920 |
3.190
|
2.890
|
288.27K | 3.91% | ||||
| Feb 23 | 3.070 | 3.220 |
3.220
|
3.060
|
145.65K | -4.66% | ||||
| Feb 22 | 3.220 | 3.220 |
3.235
|
3.180
|
125.80K | 0% | ||||